首页> 外文期刊>Oncology Research >miR-216a-3p Inhibits the Proliferation, Migration, and Invasion of Human Gastric Cancer Cells via Targeting RUNX1 and Activating the NF-kappa B Signaling Pathway
【24h】

miR-216a-3p Inhibits the Proliferation, Migration, and Invasion of Human Gastric Cancer Cells via Targeting RUNX1 and Activating the NF-kappa B Signaling Pathway

机译:MiR-216A-3P通过靶向RUNX1抑制人胃癌细胞的增殖,迁移和侵袭,并激活NF-Kappa B信号通路

获取原文
获取原文并翻译 | 示例
           

摘要

This work aims to elucidate the effects and the potential underlying mechanisms of microRNA-216a-3p (miR-216a-3p) on the proliferation, migration, and invasion of gastric cancer (GC) cells. In this study, we revealed that the expression of miR-216a-3p was significantly elevated in GC tissues and cell lines. The different expression level of miR-216a-3p was firmly correlated with clinicopathological characteristics of GC patients. We next demonstrated that upregulation of miR-216a-3p could dramatically promote the ability of proliferation, migration, and invasion of GC cells using a series of experiments, whereas downregulation essentially inhibited these properties. Additionally, through bioinformatics analysis and biological approaches, we confirmed that runt-related transcription factor 1 (RUNX1) was a direct target of miR-216a-3p, and overexpression of RUNX1 could reverse the potential effect of miR-216a-3p on GC cells. Furthermore, mechanistic investigation using Western blot analysis showed that downregulation of RUNX1 by miR-216a-3p could stimulate the activation of NF-kappa B signaling pathway. In summary, this work proved that miR-216a-3p can promote GC cell proliferation, migration, and invasion via targeting RUNX1 and activating the NF-kappa B signaling pathway. Therefore, miR-216a-3p/RUNX1 could be a possible molecular target for innovative therapeutic agents against GC.
机译:这项工作旨在阐明MicroRNA-216A-3P(miR-216A-3P)对胃癌(GC)细胞增殖,迁移和侵袭的影响和潜在的潜在基础机制。在这项研究中,我们揭示了MiR-216A-3P的表达在GC组织和细胞系中显着升高。 MiR-216A-3P的不同表达水平与GC患者的临床病理特征牢固相关。我们接下来表明MiR-216A-3P的上调可以大大促进使用一系列实验的增殖,迁移和侵袭GC细胞的能力,而下调基本上抑制了这些性质。另外,通过生物信息学分析和生物方法,我们证实Runt相关的转录因子1(Runx1)是miR-216a-3p的直接靶标,Runx1的过表达可以逆转MiR-216a-3p对GC细胞的潜在效果。此外,使用Western印迹分析的机械研究表明,MIR-216A-3P的RUNX1的下调可以刺激NF-Kappa B信号通路的激活。总之,这项工作证明,MIR-216A-3P可以通过靶向RUNX1来促进GC细胞增殖,迁移和侵袭并激活NF-Kappa B信用通路。因此,MiR-216A-3P / RUNX1可以是针对GC的创新治疗剂的可能分子靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号